Rosario, Argentina

Rolando A Spanevello


Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rolando A. Spanevello: Innovator in Peptide Synthesis

Introduction

Rolando A. Spanevello, an accomplished inventor based in Rosario, Argentina, has made significant contributions in the field of peptide synthesis. With a remarkable portfolio of three patents, he has advanced the understanding and production of somatostatin mimics, which have potential applications in biomedical research and therapeutic interventions.

Latest Patents

Spanevello's latest patents focus on synthetic somatostatin mimics. These relatively small cyclic peptides are designed to replicate the biological and chemical activities of larger cyclic peptides such as somatostatin. The patented cyclic peptides contain specific structures wherein R.sub.NP1 may include hydrogen, an amine protecting group, or a solid support, while R.sub.NP2 can be hydrogen or an amine protecting group. This innovative approach in synthetic methods offers a pathway for developing more effective peptide-based drugs.

Career Highlights

Currently, Rolando A. Spanevello is associated with the University of Pennsylvania, where he applies his expertise in peptide chemistry to both research and teaching. His work emphasizes the significance of synthetic biology in developing therapeutic options, and he is recognized as a leading figure in peptide research.

Collaborations

Throughout his career, Spanevello has collaborated with distinguished colleagues, including Ralph F. Hirschmann and Ruth F. Nutt. These partnerships have enhanced the impact of his research, facilitating innovative discoveries in the realm of cyclic peptides and their applications.

Conclusion

Rolando A. Spanevello exemplifies the spirit of innovation within the scientific community. His dedication to advancing peptide synthesis through his patents not only highlights his individual accomplishments but also contributes to the larger body of knowledge in medicinal chemistry. As he continues his work at the University of Pennsylvania, it is anticipated that his future contributions will further illuminate the potential of somatostatin mimics in therapeutic contexts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…